Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer

BACKGROUND: We examined the ability of a biopsy-based 22-marker genomic classifier (GC) to predict for distant metastases after radiation and a median of 6 months of androgen deprivation therapy (ADT). METHODS: We studied 100 patients with intermediate-risk (55%) and high-risk (45%) prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, P L, Martin, N E, Choeurng, V, Palmer-Aronsten, B, Kolisnik, T, Beard, C J, Orio, P F, Nezolosky, M D, Chen, Y-W, Shin, H, Davicioni, E, Feng, F Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435968/
https://www.ncbi.nlm.nih.gov/pubmed/28117383
http://dx.doi.org/10.1038/pcan.2016.58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435968/
https://www.ncbi.nlm.nih.gov/pubmed/28117383
http://dx.doi.org/10.1038/pcan.2016.58

Ejemplares similares